Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
The 3 “Knows” of Effective Scientific Communication
Summary
In this episode, Tom Caravela is joined by guest Linda Traylor who discusses the 3 "knows" of scientific communication for Medical Science Liaisons (MSLs). She shares the framework of scientific communication and its impact on the value and expectations of medical affairs. Self-awareness and audience analysis are emphasized to enhance engagement. The episode highlights common mistakes in audience interaction and data contextualization, offering professional development tips. It also covers storytelling techniques and strategies for effective meetings with Key Opinion Leaders (KOLs). The episode concludes with a book recommendation, acknowledgment of guest expertise, and additional resources.
Key Points
- Understanding and adapting to the evolving landscape of scientific communication, including the use of AI tools and digital platforms, is crucial for medical affairs teams.
- MSLs should focus on the three essential aspects of effective communication: knowing themselves, knowing their audience, and knowing their subject, to maximize engagements with healthcare professionals.
- Building self-awareness through tools like personality assessments, aligning communication styles with the audience to eliminate distractions, and contextualizing data within the patient, HCP, and product journeys are key strategies for successful scientific exchanges.
scientific communication, Medical Science Liaisons, audience analysis, storytelling techniques, Key Opinion Leaders
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
How to Start Presenting Like a Pro
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
Article
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
Article
Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
Article
iNIZIO